Will Adverse Drug Effects Adversely Affect Your Institution?

When considering to use the T code, simply tell the truth.

Is your institution reluctant to code a T code? Are your quality professionals concerned about being penalized for any complication that crops up during the patient stay? Are they asking the clinical documentation integrity (CDI) team to contrive by any means to avoid coding “adverse effect of drug?”

A loyal Talk Ten Tuesday listener asked whether a policy should be devised to query the provider as to whether the medication effect is inherent to avoid inappropriate penalty. It may be that you will need to query, but you need to understand the factors that enter into determining whether it is indicated or not.

We need to review definitions and concepts.

MedicationDosage EricaRemer

Reactions from medications given to the wrong patient or in the wrong dosage are considered poisoning. This is a subset of medication errors; sometimes a patient receives the wrong medication without any untoward effects. This is still considered an error. Most institutions have some internal mechanism to record and address medication errors.

We are addressing medications given to the correct patient and administered as prescribed.

Side effects are signs or symptoms that occur from therapeutically administered medication and are not unexpected. They are predictable and common and usually result in little or no change in patient management. Dry mouth from an anticholinergic is an example. Certain patient characteristics predispose a person to experience side effects, like advanced age or polypharmacy.

Not all side effects are detrimental. A glioblastoma patient who is anorexic and malnourished welcomes having his appetite stimulated by steroids. An adverse effect of a drug is when the side effect is undesirable, and it exceeds the expected level or degree of a mere side effect.

Here are some examples:
  • Nausea from an antibiotic – side effect. Erythromycin causing intractable vomiting and a Mallory-Weiss tear – T36.3X5A, adverse effect of macrolides.
  • Hypokalemia of 3.2 from diuretic requiring 40 mEq of potassium – side effect (mild hypokalemia is a known and expected consequence). Hypokalemia of 1.7 from same diuretic causing torsade de pointes requiring resuscitation and ICU monitoring – T50.1X5A, adverse effect of loop diuretics.

Let us look at adverse drug events or ADEs. The Institute of Medicine defines an ADE as “an injury resulting from medical intervention related to a drug.” It encompasses all harms occurring during medical care whether in a therapeutic or supratherapeutic dosage. Thus, ADE includes overdoses, allergic or idiosyncratic reactions, and adverse drug reactions.

Adverse drug reaction (ADRs) is the subset of ADE in which harm occurs in cases of medications at normal doses. ADR is synonymous with adverse effect of drug or adverse drug effect.

The Patient Protection and Affordable Care Act (also known as the Affordable Care Act) included changes aimed at improving health care quality and ensuring patient safety. One of the actions was to establish the National ADE Action Plan. They sought out high-priority drug classes which were commonly used and resulted in a large number of mishaps which were dangerous and largely preventable. The Steering Committee settled on anticoagulants, diabetes agents, and opioids for their initial targets.

The report is very complex and my take on it is there is no perfect way to pick up on these ADEs. There are passive voluntary reporting venues, such as the FDA Adverse Event Reporting Program (FAERS), and active surveillance systems, like AHRQ and CDC programs.

However, the key to being able to pick up these issues is utilization of the correct codes. If external causes of injury codes are not applied, the ADE may not be discoverable (unless someone were to actively read the record).

For instance, the diabetes agents that are being surveilled are associated with severe hypoglycemia, defined as requiring third-party assistance or resulting in a blood glucose lower than 40 mg/dL. Needing a sip of orange juice doesn’t qualify. The code, E11.649, Type 2 DM with hypoglycemia without coma, will not be sufficient to pick up the ADR.

Likewise, a patient with bleeding complicated by being on an anticoagulant in a purportedly therapeutic dosage should be described as D68.32, Hemorrhagic disorder due to extrinsic circulating anticoagulants with T45.515A, Adverse effect of anticoagulants. The coding should reflect the situation of the patient.

When should you pick up a T code? When it is true. I think the crux of the matter is the word, “harm.” Similar to the criteria for considering a condition a valid secondary diagnosis, there are criteria which constitute a reaction sufficiently noxious to conclude ADR. An unexpected, unintended, undesired, or excessive response to a drug that results in any of the following might qualify:

  • Requires discontinuing the drug
  • Requires changing the drug therapy
  • Requires significant dose modification
  • Necessitates admission/observation in the hospital
  • Prolongs stay in a health care facility
  • Necessitates work-up or treatment of the adverse effect
  • Significantly complicates the diagnosis or treatment
  • Results in temporary or permanent disability or death

If you are unsure, you can query. The questions you are trying to get your provider to answer are, “Is this reaction exaggerated or unusual, above and beyond what would be expected from a typical patient taking this medication at this dosage? Did the reaction require substantial additional work-up, treatment, monitoring, or did it increase length of stay?”

The question to ponder is: Is this sign or symptom typical and relatively innocuous, or is it unusual, alarming, and potentially dangerous? Former…side effect, latter…adverse drug effect and use that T code.

Use a code to represent the adverse effect, like T88.6XXA, Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered or L27.0, Generalized skin eruption due to drugs and medicaments taken internally. Then, and these even instruct us to do so, use an additional code for adverse effect from T36-T50 with fifth or sixth character 5.

If a surgeon is having more than their share of postop incision infections and dehiscence, we don’t want to do contortions to get them to represent a complication as an inherent consequence such that we can’t detect their falling out of the quality metric. We want him to wash his hands better! If a medication is causing bad reactions or having serious consequences, we don’t want to whitewash it. If it is preventable, we want to prevent it in the future. If it is a function of the medication, perhaps the medication needs to be taken off the market.

In conclusion, my answer to how to approach adverse effects is exactly the same as how to address potential postprocedural complications. Tell the truth. Let the quality metrics fall where they belong.


Program Note:

Listen to Dr. Remer every Tuesday on Talk Ten Tuesdays, 10 a.m. ET.

Comment on this article

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

Erica E. Remer, MD, CCDS

Erica Remer, MD, FACEP, CCDS, has a unique perspective as a practicing emergency physician for 25 years, with extensive coding, CDI, and ICD-10 expertise. As physician advisor for University Hospitals Health System in Cleveland, Ohio for four years, she trained 2,700 providers in ICD-10, closed hundreds of queries, fought numerous DRG clinical determination and medical necessity denials, and educated CDI specialists and healthcare providers with engaging, case-based presentations. She transitioned to independent consulting in July 2016. Dr. Remer is a member of the ICD10monitor editorial board and is the co-host on the popular Talk Ten Tuesdays weekly, live Internet radio broadcasts.

Related Stories

How to Report New Code Category W44

How to Report New Code Category W44

One of the goals of medical coding is documenting encounter notes to the highest degree of specificity. ICD-10-CM had some existing codes for documenting foreign

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Frank Cohen shows you how to leverage the Comprehensive Error Rate Testing Program (CERT) to create your own internal coding and billing risk assessment plan, including granular identification of risk areas and prioritizing audit tasks and functions resulting in decreased claim submission errors, reduced risk of audit-related damages, and a smoother, more efficient reimbursement process from Medicare.

April 9, 2024
2024 Observation Services Billing: How to Get It Right

2024 Observation Services Billing: How to Get It Right

Dr. Ronald Hirsch presents an essential “A to Z” review of Observation, including proper use for Medicare, Medicare Advantage, and commercial payers. He addresses the correct use of Observation in medical patients and surgical patients, and how to deal with the billing of unnecessary Observation services, professional fee billing, and more.

March 21, 2024
Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Explore the top-10 federal audit targets for 2024 in our webcast, “Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets,” featuring Certified Compliance Officer Michael G. Calahan, PA, MBA. Gain insights and best practices to proactively address risks, enhance compliance, and ensure financial well-being for your healthcare facility or practice. Join us for a comprehensive guide to successfully navigating the federal audit landscape.

February 22, 2024
Mastering Healthcare Refunds: Navigating Compliance with Confidence

Mastering Healthcare Refunds: Navigating Compliance with Confidence

Join healthcare attorney David Glaser, as he debunks refund myths, clarifies compliance essentials, and empowers healthcare professionals to safeguard facility finances. Uncover the secrets behind when to refund and why it matters. Don’t miss this crucial insight into strategic refund management.

February 29, 2024
2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

HIM coding expert, Kay Piper, RHIA, CDIP, CCS, reviews the guidance and updates coders and CDIs on important information in each of the AHA’s 2024 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 15, 2024

Trending News

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →